VEGF114 - Compugen
Latest Information Update: 27 Feb 2009
At a glance
- Originator Compugen
- Mechanism of Action Angiogenesis inducing agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 14 Apr 2003 Preclinical trials in Ischaemic heart disorders in USA (unspecified route)
- 14 Apr 2003 Preclinical trials in Ischaemic heart disorders in Israel (unspecified route)